The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Vagus Nerve Stimulation Therapy Randomized to Different Amounts of Electrical Charge for Treatment-Resistant Depression: Acute and Chronic Effects
Open accessAbstract
BACKGROUND Major depressive disorder is a prevalent, disabling, and often chronic or recurrent psychiatric condition. About 35% of patients fail to respond to conventional treatment approaches and are considered to have treatment-resistant depression (TRD). OBJECTIVE We compared the safety and effectiveness of different stimulation levels of adjunctive vagus nerve stimulation (VNS) therapy for the treatment of TRD. METHODS In a multicenter, double blind study, 331 patients with TRD were randomized to one of three dose groups: LOW (0.25 mA current, 130 μs pulse width), MEDIUM (0.5-1.0 mA, 250 μs), or HIGH (1.25-1.5 mA, 250 μs). A highly treatment-resistant population (>97% had failed to respond to ≥6 previous treatments) was enrolled. Response and adverse effects were assessed for 22 weeks (end of acute phase), after which output current could be increased, if clinically warranted. Assessments then continued until Week 50 (end of long-term phase). RESULTS VNS therapy was well tolerated. During the acute phase, all groups showed statistically significant improvement on the primary efficacy endpoint (change in Inventory of Depressive Symptomatology-Clinician Administered Version [IDS-C]), but not for any between-treatment group comparisons. In the long-term phase, mean change in IDS-C scores showed continued improvement. Post-hoc analyses demonstrated a statistically significant correlation between total charge delivered per day and decreasing depressive symptoms; and analysis of acute phase responders demonstrated significantly greater durability of response at MEDIUM and HIGH doses than at the LOW dose. CONCLUSIONS TRD patients who received adjunctive VNS showed significant improvement at study endpoint compared with baseline, and the effect was durable over 1 year. Higher electrical dose parameters were associated with response durability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression
Holtzheimer, P. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1456 · Cited by 608
Rush, A. J., Carmody, T., & Reimitz, P. (2000) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.79 · Cited by 427
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0902 · Cited by 390
Self-citationGeorge, M. S., Rush, A. J., Marangell, L. B., Sackeim, H. A., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Moreno, F., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.028 · Cited by 372
Self-citationDunner, D. L., Rush, A. J., Russell, J. M., Burke, M., Woodard, S., Wingard, P., & Allen, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0501 · Cited by 234 · cited 1×
“The sustained improvement was in a higher proportion of TRD patients than has been seen in treatment-as-usual studies of comparable TRD populations [5]; albeit a statistically significant improvement was not evident between dosing arms, even in the per-protocol group.”
Self-citationTwo-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178 · cited 10×
“Findings from the largest naturalistic , open - label study of VNS in TRD suggests that chronic VNS treatment leads to a cumulative increase in response over the course of the first year : 15% of patients responded to VNS at 3 months , 18% at 6 months , 23% at 9 months , and 30% at 12 months [ 8 ] .”
InfluentialMartin, J. L. R., & Martín-Sánchez, E. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.07.006 · Cited by 102
Research works printed but not linked: 16
- Marangell, 2002, Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes, Biol Psychiatry, 51, 280, 10.1016/S0006-3223(01)01343-9 · DOI · Paper page
- Rush, 2005, Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study, Biol Psychiatry, 58, 355, 10.1016/j.biopsych.2005.05.024 · DOI · Paper page
- Rush, 2005, Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial, Biol Psychiatry, 58, 347, 10.1016/j.biopsych.2005.05.025 · DOI · Paper page
- Rush, 2000, Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study, Biol Psychiatry, 47, 276, 10.1016/S0006-3223(99)00304-2 · DOI · Paper page
- Grimm, 2010, Efficacy of vagus nerve stimulation in the treatment of depression, Expert Rev Neurother, 10, 87, 10.1586/ern.09.138 · DOI
- Daban, 2008, Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review, J Affect Disord, 110, 1, 10.1016/j.jad.2008.02.012 · DOI · Paper page
- Peterchev, 2011, Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices, Brain Stimul, 5, 435, 10.1016/j.brs.2011.10.001 · DOI · Paper page
- Handforth, 1998, Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial, Neurology, 51, 48, 10.1212/WNL.51.1.48 · DOI · Paper page
- 1995, A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures, Neurology, 45, 224, 10.1212/WNL.45.2.224 · DOI · Paper page
- Sheehan, 1998, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, 59, 22
- Montgomery, 1979, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
- Hochberg, 1988, A sharper Bonferroni procedure for multiple tests of significance, Biometrika, 75, 800, 10.1093/biomet/75.4.800 · DOI · Paper page
- Sackeim, 2007, Durability of antidepressant response to vagus nerve stimulation (VNS), Int J Neuropsychopharmacol, 10, 817, 10.1017/S1461145706007425 · DOI
- Sackeim, 1990, The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression, J Clin Psychopharmacol, 10, 96, 10.1097/00004714-199004000-00004 · DOI · Paper page
- Conway, 2012, Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: A potential marker for response?, J Affect Disord, 139, 283, 10.1016/j.jad.2012.02.007 · DOI
- Lozano, 2012, A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression, J Neurosurg, 116, 315
Cited by
Milev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., Modirrousta, M., Patry, S., Vila-Rodriguez, F., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660033 · Cited by 586
Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Howland, R. H. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0010-5 · Cited by 405
Aaronson, S. T., Sears, P., Ruvuna, F., Bunker, M., Conway, C. R., Dougherty, D. D., Reimherr, F. W., Schwartz, T. L., & Zajecka, J. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16010034 · Cited by 381
Self-citationHarshaw, C. (2015) · Psychological Bulletin · doi:10.1037/a0038101 · Cited by 302
Orosz, I., McCormick, D., Zamponi, N., Varadkar, S., Feucht, M., Parain, D., Griens, R., Vallée, L., Boon, P., Rittey, C., et al. (2014) · Epilepsia · doi:10.1111/epi.12762 · Cited by 269
Self-citationSilberstein, S. D., Mechtler, L. L., Kudrow, D. B., Calhoun, A. H., McClure, C., Saper, J. R., Liebler, E. J., Rubenstein Engel, E., Tepper, S. J., & on Behalf of the ACT1 Study Group (2016) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12896 · Cited by 263
Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study
Silberstein, S. D., Calhoun, A. H., Lipton, R. B., Grosberg, B. M., Cady, R. K., Dorlas, S., Simmons, K. A., Mullin, C., Liebler, E. J., Goadsby, P. J., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002918 · Cited by 257
Treatment-resistant depression and suicidality
Bergfeld, I. O., Mantione, M., Figee, M., Schuurman, P. R., Lok, A., & Denys, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.016 · Cited by 256
Vagal nerve stimulation for treatment-resistant depression
Carreno, F. R., & Frazer, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0537-8 · Cited by 208
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Olin, B., Berry, Broglio, Bunker, Jayewardene, & Rush (2013) · Medical Devices: Evidence and Research · doi:10.2147/mder.s41017 · Cited by 152
Vagus nerve stimulation in psychiatry: a systematic review of the available evidence
Cimpianu, C.-L., Strube, W., Falkai, P., Palm, U., & Hasan, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1642-2 · Cited by 138
Widge, A. S., Ellard, K. K., Paulk, A. C., Basu, I., Yousefi, A., Zorowitz, S., Gilmour, A., Afzal, A., Deckersbach, T., Cash, S. S., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.021 · Cited by 118
The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
Grimonprez, A., Raedt, R., Baeken, C., Boon, P., & Vonck, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.019 · Cited by 81
Cook (2014) · doi:10.1016/j.nec.2013.10.002 · Cited by 69
Christmas, D., Steele, J. D., Tolomeo, S., Eljamel, M. S., & Matthews, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.080 · Cited by 57
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
de Sousa, R. T., V. Zanetti, M., R. Brunoni, A., & Machado-Vieira, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630173522 · Cited by 43
“Although its efficacy for epilepsy is well established, the evidence in depression is limited, considering that most of the data are originated from open-label studies and series of cases [144-147], with only one double-blind RCT, which showed inconclusive results [148].”
BackgroundKumar, A., Bunker, M. T., Aaronson, S. T., Conway, C. R., Rothschild, A. J., Mordenti, G., & Rush, A. J. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s196665 · Cited by 44
Self-citationA Systematic Review of Neuromodulation Treatment Effects on Suicidality
Kucuker, M. U., Almorsy, A. G., Sonmez, A. I., Ligezka, A. N., Doruk Camsari, D., Lewis, C. P., & Croarkin, P. E. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.660926 · Cited by 25
Sackeim, H. A., Dibué, M., Bunker, M. T., & Rush, A. J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s286977 · Cited by 15
Self-citationKraus, C., Quach, D., Sholtes, D. M., Kavakbasi, E., De Zwaef, R., Dibué, M., Zajecka, J., & Baune, B. T. (2022) · Neuromodulation: Technology at the Neural Interface · doi:10.1016/j.neurom.2021.12.010 · Cited by 14
Vagus nerve stimulation: Introduction and technical aspects
Pisapia, J., & Baltuch, G. (2015) · Neuromodulation in Psychiatry · doi:10.1002/9781118801086.ch17 · Cited by 11
Metadata
- Authors
- Aaronson, S. T., Carpenter, L. L., Conway, C. R., Reimherr, F. W., Lisanby, S. H., Schwartz, T. L., Moreno, F. A., Dunner, D. L., Lesem, M. D., Thompson, P. M., Husain, M., Vine, C. J., Banov, M. D., Bernstein, L. P., Lehman, R. B., Brannon, G. E., Keepers, G. A., O'Reardon, J. P., Rudolph, R. L., & Bunker, M.
- Venue
- Brain Stimulation
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 6
- Issue
- 4
- Pages
- 631-640
- ISSN
- 1876-4754 (ISSN-L)
- 1935-861X
- OpenAlex
- W1970665765
- Cited by
- 163
- References
- 10
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.